NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Actually, you’ve got the relevance and who will be driving that conversation backwards.

The FDA will be asking that question. The company has to be prepared answer. That it will likely support DCVax to have that data is irrelevant and ancillary to the FDA’s inquiry following CURRENT scientific thought before they license a drug for a given indication that has now changed in definition. But it is relevant to them as ancillary data that potentially affirms the mechanism anticipated by the science and potentially the evidence of efficacy.